Latest News
Featured News
Partnership with NHS Cancer Vaccine Launch Pad Enabling Fast-Tracked Access for Melanoma Patients
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell Change of Registered Office
First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded
First patient dosed in Modi-1 Phase 1 clinical trial
Modi-1 Phase 1/2 clinical trial open for recruitment
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.